Circulating Tumors Cells and Circulating Endothelial Cells in Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Renal Cell Carcinoma
Related studies linked through entity extraction aliases.
Study of Vitespen (HSPPC-96, Oncophage ®) for Immune Response Assessment in Participants With Resectable Renal Cell Carcinoma at Intermediate Risk of Recurrence
- Status
- TERMINATED
- Phase
- PHASE2
Study of Hydroxychloroquine Before Surgery in Patients With Primary Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1
Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD)
- Status
- COMPLETED
- Phase
- N/A
A Study of LY2584702 With Erlotinib or Everolimus in Participants With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A First in Man Study to Determine the Safety at Various Dose Levels of AGS-16M8F in Advanced Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Drug-Drug Interaction Study of the Effects of XL184 (Cabozantinib) on Rosiglitazone in Subjects With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study of Sunitinib in Subjects With High Risk Renal Cell Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE2
A Urinary Tumor Marker (Kidney Injury Molecule-1) for the Detection of Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- N/A
Efficacy of Ultrasound Contrast Agent to Assess Renal Masses
- Status
- COMPLETED
- Phase
- PHASE2
A Multi-Center, Non-Controlled Clinical Study of Sorafenib Adjuvant Therapy in Advanced Renal-Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Magnetic Resonance Imaging (MRI) in Predicting Response to Sunitinib Malate in Patients With Locally Advanced or Metastatic Kidney Cancer
- Status
- COMPLETED
- Phase
- N/A
A Prospective Study of Acute Cardiovascular Effects of First-line Sunitinib in Metastatic Renal Cell Carcinoma Patients (SUnitinib Prospective CardiovasculaR Effect)
- Status
- COMPLETED
- Phase
- N/A
Novel Prognostic Markers in Renal Cancer
- Status
- COMPLETED
- Phase
- N/A
Evaluation of the Cost and Effectiveness Sunitinib Compared to Interferon-Alfa in Finland
- Status
- COMPLETED
- Phase
- N/A
Study of the Immunoresponse in Patients Treated With a Tyrosine Kinase Inhibitor
- Status
- COMPLETED
- Phase
- N/A
Study of Lenalidomide in Combination With Sunitinib to Evaluate the Safety and Efficacy in Patients With Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Visualizing Vascular Endothelial Growth Factor (VEGF) Producing Lesions in Von Hippel-Lindau Disease
- Status
- COMPLETED
- Phase
- N/A
Arterial Spin Labeling Blood Flow Magnetic Resonance Imaging for the Evaluation of Response to Therapy in Metastatic Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- NA